Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)
Status:
Completed
Trial end date:
2016-02-24
Target enrollment:
Participant gender:
Summary
Assessed the new film-coated tablet formulation to the currently approved dispersible tablet
formulation with regards to overall safety, Gastrointestinal (GI) tolerability, palatability,
satisfaction and compliance